ロード中...
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
BACKGROUND: Inhaled corticosteroids are the recommended first-line treatment for asthma but adherence to therapy is suboptimal. The objectives of this study were to compare the efficacy and safety of once-daily (OD) evening and twice-daily (BD) regimens of the novel inhaled corticosteroid fluticason...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3282675/ https://ncbi.nlm.nih.gov/pubmed/22188590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-160 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|